↓ Skip to main content

DNA methylation profiling in doxorubicin treated primary locally advanced breast tumours identifies novel genes associated with survival and treatment response

Overview of attention for article published in Molecular Cancer, March 2010
Altmetric Badge

Mentioned by

patent
1 patent

Readers on

mendeley
100 Mendeley
citeulike
1 CiteULike
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
DNA methylation profiling in doxorubicin treated primary locally advanced breast tumours identifies novel genes associated with survival and treatment response
Published in
Molecular Cancer, March 2010
DOI 10.1186/1476-4598-9-68
Pubmed ID
Authors

Emelyne Dejeux, Jo Anders Rønneberg, Hiroko Solvang, Ida Bukholm, Stephanie Geisler, Turid Aas, Ivo G. Gut, Anne-Lise Børresen-Dale, Per Eystein Lønning, Vessela N. Kristensen, Jörg Tost

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 100 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 2 2%
Lithuania 1 1%
India 1 1%
Belgium 1 1%
Unknown 95 95%

Demographic breakdown

Readers by professional status Count As %
Researcher 25 25%
Student > Ph. D. Student 21 21%
Student > Bachelor 9 9%
Other 7 7%
Student > Master 6 6%
Other 16 16%
Unknown 16 16%
Readers by discipline Count As %
Agricultural and Biological Sciences 33 33%
Biochemistry, Genetics and Molecular Biology 21 21%
Medicine and Dentistry 21 21%
Pharmacology, Toxicology and Pharmaceutical Science 2 2%
Psychology 1 1%
Other 3 3%
Unknown 19 19%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 09 November 2023.
All research outputs
#8,344,541
of 24,946,857 outputs
Outputs from Molecular Cancer
#667
of 1,876 outputs
Outputs of similar age
#37,133
of 100,454 outputs
Outputs of similar age from Molecular Cancer
#5
of 21 outputs
Altmetric has tracked 24,946,857 research outputs across all sources so far. This one is in the 43rd percentile – i.e., 43% of other outputs scored the same or lower than it.
So far Altmetric has tracked 1,876 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.6. This one has gotten more attention than average, scoring higher than 52% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 100,454 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 21st percentile – i.e., 21% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 21 others from the same source and published within six weeks on either side of this one. This one is in the 19th percentile – i.e., 19% of its contemporaries scored the same or lower than it.